Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: Prosper long-term follow-up

Diabetologia

Volumn 57, Issue 12, 2014, Pages 2513-2520

  Welsh, Paul ^a   Preiss, David ^a   Lloyd, Suzanne M ^b   de Craen, Anton J ^c   Jukema, J Wouter ^c   Westendorp, Rudi G ^c   Buckley, Brendan M ^d   Kearney, Patricia M ^e   Briggs, Andrew ^b   Stott, David J ^b   Ford, Ian ^b   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d University College Cork and INFANT Centre   (Ireland)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

All cause mortality; Cardiovascular disease; Insulin resistance; Risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO; PRAVASTATIN; GLUCOSE BLOOD LEVEL;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERIATRIC DISORDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; MORTALITY; PROSPECTIVE STUDIES; RISK;

EID: 84926635836     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3383-9     Document Type: Article

References (24)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
2. Sattar N, McConnachie A, Shaper AG et al (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927–1935
3. Preiss D, Welsh P, Murray HM et al (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 31:1230–1236
4. Welsh P, Murray HM, Buckley BM et al (2009) Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308–310
5. Emerging Risk Factors Collaboration (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375: 2215–2222
6. Tsuchiya K, Tanaka J, Shuiqing Y et al (2012) FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab 15:372–381
7. DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270–1287
8. Sarwar N, Sattar N, Gudnason V, Danesh J (2007) Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart J 28:2491–2497
9. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM (2012) Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 7:e52036
10. Shepherd J, Blauw GJ, Murphy MB et al (2002) PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623–1630
11. Lloyd SM, Stott DJ, de Craen AJ et al (2013) Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS ONE 8:e72642
12. Shepherd J, Blauw GJ, Murphy MB et al (1999) The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. Am J Cardiol 84:1192–1197
13. Sattar N, Murray HM, Welsh P et al (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med 6:e1000099
14. Reddy KJ, Singh M, Bangit JR, Batsell RR (2010) The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med 11:633–647
15. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106:453–458
16. Lim S, Hong J, Liu CT et al (2013) Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study. Atherosclerosis 29:149–154
17. Preiss D, Lloyd S, Ford I et al (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol 2:116–124
18. Lexis CP, van der Horst IC, Lipsic E et al (2014) Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA 311:1526–1535
19. Hanley AJ, Williams K, Gonzalez C et al (2003) Insulin Resistance Atherosclerosis Study. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463–469
20. Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63
21. Kozakova M, Natali A, Dekker J (2013) Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. Arterioscler Thromb Vasc Biol 33:1409–1417
22. Otten J, Ahrén B, Olsson T (2014) Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia 57:1781–1788
23. Petrie JR (2014) Evidence-based estimation of insulin resistance. Diabetologia 57:1743–1745
24. Welsh P, Murray HM, Ford I et al (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arterioscler Thromb Vasc Biol 31:2338–2344